NASDAQ:CALTLegend Biotech Stock Price, Forecast & News

News coverage about CALT stock has trended very negative this week, according to InfoTrie Sentiment. The research group ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Legend Biotech earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Legend Biotech.

Some companies that are related to Legend Biotech include Principia Biopharma (PRNB), Myovant Sciences (MYOV), Xencor (XNCR), Prestige Consumer Healthcare (PBH), Y-mAbs Therapeutics (YMAB), Ligand Pharmaceuticals (LGND), Aurinia Pharmaceuticals (AUPH), Madrigal Pharmaceuticals (MDGL), Eidos Therapeutics (EIDX), Passage Bio (ZNTL), I-Mab (IMAB), Intra-Cellular Therapies (ITCI), Ironwood Pharmaceuticals (IRWD), Akebia Therapeutics (AKBA) and Zymeworks (ZYME). View all competitors.

(CALT) raised $179 million in an initial public offering (IPO) on Friday, June 5th 2020. The company issued 9,200,000 shares at a price of $19.50 per share. Citigroup, Jefferies and Stifel served as the underwriters for the IPO and Carnegie was co-manager.

Legend Biotech trades on the NASDAQ under the ticker symbol "CALT."

Legend Biotech's quiet period expires on Wednesday, July 15th. Legend Biotech had issued 4,153,385 shares in its initial public offering on June 5th. The total size of the offering was $80,991,008 based on an initial share price of $19.50. During Legend Biotech's quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Shares of CALT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CALT stock can currently be purchased for approximately $23.61.

Legend Biotech has a market capitalization of $565.79 million. Legend Biotech employs 17 workers across the globe.

The official website for Legend Biotech is www.calliditas.se.

Legend Biotech's mailing address is KUNGSBRON 1 C8, STOCKHOLM V7, 11122. The company can be reached via phone at 46-8411-3005 or via email at [email protected]